{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:52:36Z","timestamp":1792857156043,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS 109668"],"award-info":[{"award-number":["NS 109668"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS112788"],"award-info":[{"award-number":["NS112788"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS113955"],"award-info":[{"award-number":["NS113955"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neuropharm.2022.109349","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:15:58Z","timestamp":1669295758000},"page":"109349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Riluzole and novel naphthalenyl substituted aminothiazole derivatives prevent acute neural excitotoxic injury in a rat model of temporal lobe epilepsy"],"prefix":"10.1016","volume":"224","author":[{"given":"Thomas","family":"Kyllo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesung","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Singh","family":"Latika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai M.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Je","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4598-9898","authenticated-orcid":false,"given":"Jeffrey D.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109349_bib1","first-page":"12","article-title":"Biological aspects of emerging benzothiazoles: a short review","author":"Ali","year":"2013","journal-title":"J. Chem."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109349_bib2","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1152\/jn.00665.2001","article-title":"Block of glutamate-glutamine cycle between astrocytes and neurons inhibits epileptiform activity in hippocampus","volume":"88","author":"Bacci","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","article-title":"A review of the neural mechanisms of action and clinical efficiency of riluzole in treating Amyotrophic Lateral Sclerosis: what we have learned in the last decade?","volume":"17","author":"Bellingham","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2022.109349_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0306-4522(85)90299-4","article-title":"Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy","volume":"14","author":"Ben Ari","year":"1985","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109349_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.seizure.2021.02.031","article-title":"Two decades of research toward a potential first anti-epileptic drug","volume":"90","author":"Benassi","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2022.109349_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/088307389701200802","article-title":"Glutamate in neurologic diseases","volume":"12","author":"Bittigau","year":"1997","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1750-3639.2012.00583.x","article-title":"Defining clinico-neuropathological subtypes of mesial temporal lobe epilepsy with hippocampal sclerosis","volume":"22","author":"Blumcke","year":"2012","journal-title":"Brain Pathol."},{"issue":"5231","key":"10.1016\/j.neuropharm.2022.109349_bib8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1126\/science.7569903","article-title":"Regulation of hippocampal transmitter release during development and long-term potentiation","volume":"269","author":"Bolshakov","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109349_bib9","first-page":"187","article-title":"Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice","volume":"56","author":"Borowicz","year":"2004","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4522(98)00401-1","article-title":"Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy","volume":"89","author":"Bouilleret","year":"1999","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109349_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cne.20354","article-title":"Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters","volume":"480","author":"Boulland","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0306-4522(03)00027-7","article-title":"N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy","volume":"118","author":"Brandt","year":"2003","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109349_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jnr.490350513","article-title":"Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination","volume":"35","author":"Brewer","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-016-0406-8","article-title":"Tolerability and safety of commonly used antiepileptic drugs in adolescents and adults: a clinician's overview","volume":"31","author":"Brodie","year":"2017","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109349_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1523\/JNEUROSCI.22-01-00062.2002","article-title":"Glutamine uptake by neurons: interaction of protons with system A transporters","volume":"22","author":"Chaudhry","year":"2002","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109349_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1083\/jcb.200201070","article-title":"The glutamine commute: take the N line and transfer to the A","volume":"157","author":"Chaudhry","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/sj.jcbfm.9600490","article-title":"Glutamatergic and GABAergic neurotransmitter cycling and energy metabolism in rat cerebral cortex during postnatal development","volume":"27","author":"Chowdhury","year":"2007","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109349_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/physrev.1990.70.1.43","article-title":"Role of amino acid transport and countertransport in nutrition and metabolism","volume":"70","author":"Christensen","year":"1990","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109349_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0014-4886(82)90109-1","article-title":"Effect of anticonvulsant drugs on kainic acid-induced epileptiform activity","volume":"76","author":"Clifford","year":"1982","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s13311-014-0305-y","article-title":"The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant","volume":"12","author":"Coleman","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2022.109349_bib21","first-page":"305","article-title":"Liquid chromatographic assay for riluzole in mouse plasma and central nervous system tissues","volume":"803","author":"Colovic","year":"2004","journal-title":"J. Chromatogr."},{"issue":"6\u20137","key":"10.1016\/j.neuropharm.2022.109349_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neuint.2005.11.016","article-title":"The glutamine commute: lost in the tube?","volume":"48","author":"Conti","year":"2006","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109349_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"31","key":"10.1016\/j.neuropharm.2022.109349_bib24","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1523\/JNEUROSCI.5221-04.2005","article-title":"Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits","volume":"25","author":"De Gois","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-2999(93)90147-A","article-title":"Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes","volume":"235","author":"Debono","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109349_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1471-4159.2003.01981.x","article-title":"Glutamine efflux from astrocytes is mediated by multiple pathways","volume":"87","author":"Deitmer","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1523\/JNEUROSCI.23-05-01563.2003","article-title":"Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling","volume":"23","author":"Deken","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib28","volume":"4","author":"Devinsky","year":"2018","journal-title":"Epilepsy. Nat. Rev. Dis. Primers"},{"issue":"6 Suppl. 4","key":"10.1016\/j.neuropharm.2022.109349_bib29","first-page":"S233","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.109349_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1015255312948","article-title":"Excited to death: different ways to lose your neurons","volume":"3","author":"Dodd","year":"2002","journal-title":"Biogerontology"},{"key":"10.1016\/j.neuropharm.2022.109349_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0079-6123(07)63041-6","article-title":"Epileptogenesis in the dentate gyrus: a critical perspective","volume":"163","author":"Dudek","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2353\/ajpath.2010.090119","article-title":"Experimental neonatal status epilepticus and the development of temporal lobe epilepsy with unilateral hippocampal sclerosis","volume":"176","author":"Dunleavy","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib33","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0026-895X(24)26499-3","article-title":"The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK","volume":"57","author":"Duprat","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib34","doi-asserted-by":"crossref","DOI":"10.1046\/j.1528-1157.43.s.5.39.x","article-title":"Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat","author":"Ebert","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2022.109349_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jnc.14046","article-title":"Functional identification of activity-regulated, high-affinity glutamine transport in hippocampal neurons inhibited by riluzole","volume":"142","author":"Erickson","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1568026053386872","article-title":"Voltage gated ion channels: targets for anticonvulsant drugs","volume":"5","author":"Errington","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib37","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1523\/JNEUROSCI.23-30-09697.2003","article-title":"Vesicular localization and activity-dependent trafficking of presynaptic choline transporters","volume":"23","author":"Ferguson","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3565(25)33603-7","article-title":"Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids","volume":"225","author":"Ferkany","year":"1983","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109349_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0387-7604(98)00069-2","article-title":"Hippocampal sclerosis revisited","volume":"20","author":"Fisher","year":"1998","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2022.109349_bib40","first-page":"355","article-title":"Only certain anticonvulsants protect against kainate neurotoxicity","volume":"3","author":"Fuller","year":"1981","journal-title":"Neurobehav. Toxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2007.10.023","article-title":"Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1","volume":"578","author":"Fumagalli","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109349_bib42","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1471-4159.1972.tb06226.x","article-title":"The free amino acids in human cerebrospinal fluid","volume":"19","author":"Gjessing","year":"1972","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0028-3908(01)00028-4","article-title":"Pharmacological modulation of SK3 channels","volume":"40","author":"Grunnet","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109349_bib44","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-015-0545-1","article-title":"Glutamate and GABA imbalance following traumatic brain injury","author":"Guerriero","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109349_bib45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hipo.1076","article-title":"Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling","volume":"11","author":"Haas","year":"2001","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2022.109349_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030464","article-title":"Ionotropic glutamate receptors in epilepsy: a review focusing on AMPA and NMDA receptors","volume":"10","author":"Hanada","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2022.109349_bib47","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1523\/JNEUROSCI.20-04-01342.2000","article-title":"Neuronal pyruvate carboxylation supports formation of transmitter glutamate","volume":"20","author":"Hassel","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0306-4522(00)00146-9","article-title":"The multifarious hippocampal mossy fiber pathway: a review","volume":"98","author":"Henze","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109349_bib49","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0026-895X(25)10187-9","article-title":"Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole","volume":"45","author":"Herbert","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2013.00059","article-title":"The glutamate-glutamine (GABA) cycle: importance of late postnatal development and potential reciprocal interactions between biosynthesis and degradation","volume":"4","author":"Hertz","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib51","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.59.9_suppl_5.S3","article-title":"Seizure-induced neuronal injury: animal data","volume":"59","author":"Holmes","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.109349_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0006-8993(00)02137-5","article-title":"Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain","volume":"864","author":"Hopkins","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/cr020033s","article-title":"The combinatorial synthesis of bicyclic privileged structures or privileged substructures","volume":"103","author":"Horton","year":"2003","journal-title":"Chem. Rev."},{"key":"10.1016\/j.neuropharm.2022.109349_bib54","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-3565(24)36931-9","article-title":"Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons","volume":"282","author":"Huang","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109349_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1871524915666150112094206","article-title":"Anticonvulsant and neurological profile of benzothiazoles: a mini-review","volume":"15","author":"Jagbir","year":"2015","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/brain\/awh358","article-title":"Temporal lobe epilepsy with hippocampal sclerosis: predictors for long-term surgical outcome","volume":"128","author":"Janszky","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2022.109349_bib57","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0968-0896(00)82179-3","article-title":"Synthesis, anticonvulsant and neuroprotective activities of RP 66055, a riluzole derivative","volume":"2","author":"Jimonet","year":"1994","journal-title":"Bioorg. Med. Chem."},{"issue":"34","key":"10.1016\/j.neuropharm.2022.109349_bib58","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.1198-07.2007","article-title":"Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle","volume":"27","author":"Kam","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s13311-014-0266-1","article-title":"The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments","volume":"11","author":"Kaminski","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109349_bib60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1471-4159.2004.02478.x","article-title":"Quantitative determination of extracellular glutamine concentration in rat brain, and its elevation in vivo by system A transport inhibitor, alpha-(methylamino)isobutyrate","volume":"90","author":"Kanamori","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.brainres.2010.11.064","article-title":"Chronic electrographic seizure reduces glutamine and elevates glutamate in the extracellular fluid of rat brain","volume":"1371","author":"Kanamori","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eplepsyres.2013.08.007","article-title":"Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus","volume":"107","author":"Kanamori","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2007.04.018","article-title":"Anti-glutamatergic effect of riluzole: comparison with valproic acid","volume":"147","author":"Kim","year":"2007","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109349_bib64","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jnr.10041","article-title":"Kinetics and localization of brain phosphate activated glutaminase","volume":"66","author":"Kvamme","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-319-45096-4_8","article-title":"The glutamine transporters and their role in the glutamate\/GABA-glutamine cycle","volume":"13","author":"Leke","year":"2016","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib66","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.neubiorev.2013.10.011","article-title":"The kainic acid model of temporal lobe epilepsy","volume":"37","author":"Levesque","year":"2013","journal-title":"Neurosci Behav Rev"},{"key":"10.1016\/j.neuropharm.2022.109349_bib67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3940(99)00810-1","article-title":"Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes","volume":"276","author":"Lingamaneni","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109349_bib68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1602\/neurorx.1.1.101","article-title":"Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults","volume":"1","author":"Lipton","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2022.109349_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.04.011","article-title":"The holy grail of epilepsy prevention: preclinical approaches to antiepileptogenic treatments","volume":"167","author":"Loscher","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109349_bib157","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond","volume":"35","author":"Loscher","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2022.109349_bib70","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"Loscher","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2022.109349_bib71","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2012.222","article-title":"Perampanel-new promise for refractory epilepsy?","volume":"8","author":"Loscher","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib72","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"Loscher","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109349_bib73","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s00424-003-1117-9","article-title":"Sodium-coupled neutral amino acid (System N\/A) transporters of the SLC38 gene family","volume":"447","author":"Mackenzie","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"26","key":"10.1016\/j.neuropharm.2022.109349_bib74","doi-asserted-by":"crossref","first-page":"23720","DOI":"10.1074\/jbc.M212718200","article-title":"Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons","volume":"278","author":"Mackenzie","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s43088-022-00278-0","article-title":"Pharmacological perspectives and mechanisms involved in epileptogenesis","volume":"11","author":"Marques","year":"2022","journal-title":"Beni-Suef Univ J Basic Appl. Sci"},{"key":"10.1016\/j.neuropharm.2022.109349_bib76","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0014-2999(93)90037-I","article-title":"The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1","volume":"250","author":"Martin","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib77","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/jnr.23561","article-title":"Maintaining the presynaptic glutamate supply for excitatory neurotransmission","volume":"93","author":"Marx","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib78","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1523\/JNEUROSCI.4241-05.2006","article-title":"Mice lacking brain\/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth","volume":"26","author":"Masson","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0166-2236(90)90178-D","article-title":"Amino acid neurotransmission: spotlight on synaptic vesicles","volume":"13","author":"Maycox","year":"1990","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109349_bib80","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.1977.tb09621.x","article-title":"Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals","volume":"29","author":"McGale","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib81","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41583-020-00418-4","article-title":"Sodium channelopathies in neurodevelopmental disorders","volume":"22","author":"Meisler","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nurt.2006.11.010","article-title":"Molecular targets for antiepileptic drug development","volume":"4","author":"Meldrum","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109349_bib83","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/cercor\/bhh018","article-title":"Localization of the glutamine transporter SNAT1 in rat cerebral cortex and neighboring structures, with a note on its localization in human cortex","volume":"14","author":"Melone","year":"2004","journal-title":"Cerebr. Cortex"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109349_bib84","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuroscience.2006.02.042","article-title":"Localization of the Na(+)-coupled neutral amino acid transporter 2 in the cerebral cortex","volume":"140","author":"Melone","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109349_bib85","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0028-3908(85)90011-5","article-title":"2-amino-6-trifuoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission: I. Anti-convulsant properties","volume":"24","author":"Mizoule","year":"1985","journal-title":"Neuropharmacology"},{"issue":"46","key":"10.1016\/j.neuropharm.2022.109349_bib86","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1523\/JNEUROSCI.2556-06.2006","article-title":"Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain","volume":"26","author":"Moechars","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2005.12.002","article-title":"Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists","volume":"6","author":"Muir","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2020.09.015","article-title":"Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: from pathogenesis to treatment target","volume":"82","author":"Mukhtar","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2022.109349_bib89","first-page":"201","volume":"vol. 116","author":"Mullen","year":"1992"},{"key":"10.1016\/j.neuropharm.2022.109349_bib90","first-page":"395","article-title":"Role of excitatory pathways in the hippocampal damage produced by kainic acid","volume":"27","author":"Nadler","year":"1981","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib91","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0306-4522(84)90289-6","article-title":"Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae","volume":"13","author":"Nitecka","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109349_bib92","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/nbdi.2000.0297","article-title":"A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C","volume":"7","author":"Noh","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109349_bib93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(79)90071-4","article-title":"Fine structural localization of glutamine synthetase in astrocytes of rat brain","volume":"161","author":"Norenberg","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib94","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-physiol-021014-071846","article-title":"Sodium channel B subunits: emerging targets in channelopathies","volume":"77","author":"O'Malley","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105230","article-title":"Voltage gated sodium channel inhibitors as anticonvulsant drugs: a systematic review on recent developments and structure activity relationship studies","volume":"115","author":"Pal","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib96","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/acsmedchemlett.8b00189","article-title":"Dipeptide prodrugs of the glutamate modulator riluzole","volume":"9","author":"Pelletier","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2022.109349_bib97","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib98","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2005.00506.x","article-title":"Adverse effects of antiepileptic drugs","volume":"181","author":"Perucca","year":"2005","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neuropharm.2022.109349_bib99","first-page":"1","article-title":"Molecular, structural, functional, and pharmacological sites for vesicular glutamate transporter regulation","volume":"30","author":"Pietrancosta","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(02)00073-X","article-title":"Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy","volume":"1","author":"Pitkanen","year":"2002","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib101","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0304-3940(94)11166-G","article-title":"Early and transient increase of rat hippocampal blood-brain barrier permeability to amino acids during kainic acid-induced seizures","volume":"184","author":"Pont","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109349_bib102","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0896-6273(00)81203-9","article-title":"Selective depression of low-release probability excitatory synapses by sodium channel blockers","volume":"26","author":"Prakriya","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109349_bib103","first-page":"1","article-title":"Benzothiazole: the molecule of diverse biological activities","volume":"2","author":"Priyanka","year":"2010","journal-title":"Int. J. Curr. Pharmaceut. Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib104","first-page":"281","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Neurophysiology"},{"issue":"14","key":"10.1016\/j.neuropharm.2022.109349_bib105","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1073\/pnas.140152797","article-title":"Amino acid transport system A resembles system N in sequence but differs in mechanism","volume":"97","author":"Reimer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109349_bib106","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","article-title":"Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy","volume":"112","author":"Riban","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109349_bib107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cts.12448","article-title":"Importance of drug pharmacokinetics at the site of action","volume":"10","author":"Rizk","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib108","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1021\/ja5031744","article-title":"Palau\u2019chlor: a practical and reactive chlorinating reagent","volume":"136","author":"Rodriguez","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2022.109349_bib109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ane.12099","article-title":"AMPA receptors as a molecular target in epilepsy therapy","volume":"Suppl","author":"Rogawski","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2022.109349_bib110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0014-2999(91)90503-I","article-title":"Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy","volume":"199","author":"Romettino","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib111","doi-asserted-by":"crossref","first-page":"C783","DOI":"10.1152\/ajpcell.00070.2007","article-title":"The TTX metabolite 4,9-andydro-TTX is a highly specific blocker of the Na-v1.6 voltage-dependent sodium channel","volume":"293","author":"Rosker","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib112","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109349_bib113","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0337-20.2021","article-title":"The kainic acid models of temporal lobe epilepsy","volume":"8","author":"Rusina","year":"2021","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2022.109349_bib114","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6606-3-40","article-title":"The physiological roles of vesicular GABA transporter during embryonic development: a study using knockout mice","volume":"3","author":"Saito","year":"2010","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2022.109349_bib115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-0035-1558984","article-title":"Amyotrophic lateral sclerosis: review","volume":"35","author":"Salameh","year":"2015","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib116","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nbd.2018.06.017","article-title":"In search of antiepileptogenic treatments for post-traumatic epilepsy","volume":"123","author":"Saletti","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109349_bib117","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/mol.108.051425","article-title":"Naphtho[1,2-d]thiazol-2-ylamine (SLA-31, a new activator of KCa2 and KCa3.1 potassium channels), potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure","volume":"75","author":"Sankaranarayanan","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12368-6","article-title":"A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy","author":"Schidlitzki","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109349_bib119","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-8993(00)02513-0","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration","volume":"874","author":"Schmued","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109349_bib120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<99::AID-GLIA11>3.0.CO;2-W","article-title":"Trafficking between glia and neurons of TCA cycle intermediates and related metabolites","volume":"21","author":"Schousboe","year":"1997","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2022.109349_bib121","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/01926230701748305","article-title":"Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions","volume":"35","author":"Sharma","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109349_bib122","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/14756366.2012.720572","article-title":"Medicinal significance of benzothiazole scaffold: an insight view","volume":"28","author":"Sharma","year":"2012","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib123","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2022.109349_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00972","article-title":"The trials and tribulations of structure assisted design of KCa Channel activators","author":"Shim","year":"2019","journal-title":"Front. Pharmacol. doi.org\/"},{"key":"10.1016\/j.neuropharm.2022.109349_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109349_bib126","doi-asserted-by":"crossref","first-page":"a022848","DOI":"10.1101\/cshperspect.a022848","article-title":"Epilepsy: a spectrum disorder","volume":"5","author":"Sirven","year":"2015","journal-title":"Cold Spring Harb. Perspect Med."},{"key":"10.1016\/j.neuropharm.2022.109349_bib127","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3565(24)36856-9","article-title":"Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels","volume":"282","author":"Song","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109349_bib128","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00001756-200207020-00019","article-title":"Lamotrigine derivatives and riluzole inhibit INa2P in cortical neurons","volume":"13","author":"Spadoni","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2022.109349_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(94)90019-1","article-title":"Kainic acid seizures in the rat","volume":"42","author":"Sperk","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1091581820928497","article-title":"Quantitative Neurotoxicology: an assessment of the neurotoxic profile of kainic acid in Sprague Dawley rats","volume":"39","author":"Srivastava","year":"2020","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/exnr.1997.6554","article-title":"Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies","volume":"147","author":"Stefani","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib132","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/tx200168d","article-title":"Structural alert\/reactive metabolite concept as applied in medicinal chamistry to mitigate the risk of idiosyncratic drug toxicity; a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States","volume":"24","author":"Stepan","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib133","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1527-3458.1997.tb00318.x","article-title":"Neuroprotective profile of riluzole in in vivo models of acute neurodegenerative diseases","volume":"3","author":"Stutzmann","year":"1997","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2022.109349_bib134","article-title":"Calcium control of neurotransmitter release","volume":"41","author":"Sudhof","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"6801","key":"10.1016\/j.neuropharm.2022.109349_bib135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/35025070","article-title":"Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons","volume":"407","author":"Takamori","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109349_bib136","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1471-4159.2012.07684.x","article-title":"Synaptic vesicles are capable of synthesizing the VGLUT substrate glutamate from \u03b1-ketoglutarate for vesicular loading","volume":"121","author":"Takeda","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00301","article-title":"Drug-resistant epilepsy: multiple hypotheses, few answers","author":"Tang","year":"2017","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109349_bib138","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.nbd.2006.08.025","article-title":"Modulation of epileptiform activity by glutamine and system A transport in a model of post-traumatic epilepsy","volume":"25","author":"Tani","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109349_bib139","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1523\/JNEUROSCI.0106-09.2010","article-title":"Glutamine is required for persistent epileptiform activity in the disinhibited neocortical brain slice","volume":"30","author":"Tani","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib140","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.neuron.2013.12.026","article-title":"A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release","volume":"81","author":"Tani","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109349_bib141","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/md13020984","article-title":"Selective blocking effects of 4,9-anhydrotetrodotoxin, purified from a crude mixture of tetrodotoxin analogues, on NaV1.6 channels and its chemical aspects","volume":"13","author":"Teramoto","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.neuropharm.2022.109349_bib142","first-page":"HS15","article-title":"Behavioral side effects of antiepileptic drugs","volume":"38","author":"Thigpen","year":"2013","journal-title":"U.S. Pharm."},{"key":"10.1016\/j.neuropharm.2022.109349_bib143","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/nan.12150","article-title":"Review: hippocampal sclerosis in epilepsy: a neuropathology review","volume":"40","author":"Thom","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib144","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/acs.molpharmaceut.8b00064","article-title":"Intracellular drug bioavailability: effect of neutral lipids and phospholipids","volume":"15","author":"Treyer","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuropharm.2022.109349_bib145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmech.2012.03.045","article-title":"Quinazolino-benzothiazoles: fused pharmacophores as anticonvulsant agents","volume":"53","author":"Ugale","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109349_bib146","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1074\/jbc.275.6.4049","article-title":"Cloning and functional identification of a neuronal glutamine transporter","volume":"275","author":"Varoqui","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib147","doi-asserted-by":"crossref","first-page":"19716","DOI":"10.1021\/acsami.6b01776","article-title":"Enhancement in the neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle","volume":"8","author":"Verma","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.neuropharm.2022.109349_bib148","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib149","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1533-2500.2004.04304.x","article-title":"Side effects of antiepileptics - a review","volume":"4","author":"Walia","year":"2004","journal-title":"Pain Pract."},{"key":"10.1016\/j.neuropharm.2022.109349_bib151","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2004.01.019","article-title":"Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109349_bib152","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/MN:31:1-3:003","article-title":"Kainic acid-mediated excitotoxicity as a model for neurodegeneration","volume":"31","author":"Wang","year":"2005","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109349_bib153","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1152\/jn.00464.2004","article-title":"Developmental changes in release properties of the CA3-CA1 glutamate synapse in rat hippocampus","volume":"92","author":"Wasling","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109349_bib154","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/14737175.3.6.821","article-title":"Hippocampal sclerosis and the syndrome of medial temporal lobe epilepsy","volume":"3","author":"Watson","year":"2003","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2022.109349_bib155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-3806(03)00107-X","article-title":"Ontogeny of the neutral amino acid transporter SAT1\/ATA1 in rat brain","volume":"143","author":"Weiss","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.neuropharm.2022.109349_bib156","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"White","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2022.109349_bib164","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1523\/JNEUROSCI.3003-04.2005","article-title":"Presynaptic regulation of quantal size by the vesicular glutamate transporter (VGLUT1)","volume":"25","author":"Wilson","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109349_bib158","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0014-4886(91)90042-B","article-title":"Age-related sensitivity to kainate neurotoxicity","volume":"114","author":"Wozniak","year":"1991","journal-title":"Exp. Neurol."},{"issue":"30","key":"10.1016\/j.neuropharm.2022.109349_bib159","doi-asserted-by":"crossref","first-page":"22790","DOI":"10.1074\/jbc.M002965200","article-title":"A novel system A isoform mediating Na+\/neutral amino acid cotransport","volume":"275","author":"Yao","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109349_bib160","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0306-4522(97)00604-0","article-title":"Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons","volume":"85","author":"Zona","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109349_bib161","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/syn.10040","article-title":"Kainate-induced currents in rat cortical neurons in culture are modulated by riluzole","volume":"43","author":"Zona","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2022.109349_bib162","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0014-4886(83)90223-6","article-title":"Blood-brain barrier changes with kainic acid-induced limbic seizures","volume":"79","author":"Zucker","year":"1983","journal-title":"Exp. Neurol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:25:09Z","timestamp":1758439509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822004087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":163,"alternative-id":["S0028390822004087"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109349","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Riluzole and novel naphthalenyl substituted aminothiazole derivatives prevent acute neural excitotoxic injury in a rat model of temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109349"}}